Menu
Crohns sjukdom
Korta föreläsningar
5-årsdata CD
Säkerhet
Stardust
IBD & Stelaras verkningsmekanism
Immunogenicitet
Vetenskapliga artiklar
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
Five-Year Efficacy and Safety of Ustekinumab Treatment in
Crohn’s Disease: The IM-UNITI Trial
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn’s Disease
Kontakta gärna
Sofia Helmersson, PhD
Key Account Manager Gastro
Södra & västra Sverige
Mob/sms: +46 73 039 73 25
shelmers@its.jnj.com
Linda Nilsson, Leg. SSK
Key Account Manager Gastro
Stockholm & norra Sverige
Mob/sms: +46 73 076 99 37
lnilsso3@its.jnj.com
